© 2001 European Society of Cardiology
Clinical profile and management of heart failure: rural community hospital vs. metropolitan heart center
a Herzzentrum Ludwigshafen, Department of Cardiology Bremserstraße 79, 67063 Ludwigshafen, Germany
b 1st Medical Department Diakoniekrankenhaus Rotenburg, Elise Averdieck Straße, 27356 Rotenburg, Germany
* Corresponding author. Herzzentrum Ludwigshafen, Medizinische Klinik B, Bremserstr. 79, 67063 Ludwigshafen, Germany. Tel.: +49-6215034000; fax: +49-6215034044. E-mail address: gtau1904{at}aol.com (G. Taubert)
 |
Abstract |
|---|
Background: Knowledge on clinical characteristics and prognosis of patients with heart failure originates from studies of selected populations in clinical trials or from epidemiological observations. Reports on the large numbers of patients with heart failure treated in community hospitals are sparse.
Objective: Are there differences in patient characteristics and heart failure management between a metropolitan heart center (HC) and a rural community hospital (RCH)?
Patients and methods: Retrospective analysis of medical charts from all patients admitted for heart failure (ICD 428.x, NYHA II–IV, EF < 45%) between May 1997 and April 1998 and discharged alive from a rural community hospital. A similar, but prospective registry was available at the HC. Follow-up information was obtained by request at registration authorities.
Results: Patient groups comprised 120 in RCH and 146 in HC. Mean age was 75 ± 11 and 66 ± 11 years, respectively (P < 0.001); 48% (RCH) vs. 74% (HC) of patients were male (P < 0.001). On admission the proportion of functional class IV was 69% (RCH) vs. 17% (HC) (P < 0.001). At discharge, the rate of ACE-inhibitors was 74% (RCH) vs. 98% (HC); 11% (RCH) vs. 43% (HC) of patients received β-blocker therapy. Ninety-six percent of patients in HC underwent and 22% in RCH had undergone invasive diagnostics. One-year mortality rate of patients discharged alive was 26% in RCH and 19% in HC (P = n.s. after adjustment for age and gender).
Conclusion: Heart failure management according to current guidelines, using β-blockers and ACE inhibitors, and invasive cardiac examination was significantly less performed in the rural community hospital than in the metropolitan heart center. Therefore, strategies to improve heart failure management according to guidelines are urgently needed.
Key Words: Clinical characteristics • Prognosis • Heart failure
Received December 30, 1999; Revised January 8, 2001; Accepted February 12, 2001
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, and J. J.V. McMurray Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail, February 1, 2009; 11(2): 130 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. de Groote, R. Isnard, P. Clerson, G. Jondeau, M. Galinier, P. Assyag, N. Demil, A. Ducardonnet, J.-F. Thebaut, and M. Komajda Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme Eur J Heart Fail, January 1, 2009; 11(1): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Erhardt, M. Komajda, F.D. R. Hobbs, and J. Soler-Soler Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey Eur J Heart Fail, October 1, 2008; 10(10): 1020 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lainscak, J. G.F. Cleland, M. J. Lenzen, F. Follath, M. Komajda, and K. Swedberg International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey Eur J Heart Fail, March 1, 2007; 9(3): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Weller, E. K. Wai, S. Jaglal, and H. J. Kreder The effect of hospital type and surgical delay on mortality after surgery for hip fracture J Bone Joint Surg Br, March 1, 2005; 87-B(3): 361 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tandon, F. A. McAlister, R. T. Tsuyuki, M. Hervas-Malo, R. Dupuit, J. Ezekowitz, B. Cujec, and P. W. Armstrong The Use of {beta}-Blockers in a Tertiary Care Heart Failure Clinic: Dosing, Tolerance, and Outcomes Arch Intern Med, April 12, 2004; 164(7): 769 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murray-Thomas and M. R Cowie Epidemiology and clinical aspects of congestive heart failure Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 131 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 The Study Group of Diagnosis of the Working Group, M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, A. Cohen-Solal, R. Dietz, A. Gavazzi, W.H. Van Gilst, et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe: Part 2: treatment Eur. Heart J., March 1, 2003; 24(5): 464 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Bouvy, E. R. Heerdink, H. G.M. Leufkens, and A. W. Hoes Patterns of pharmacotherapy in patients hospitalised for congestive heart failure Eur J Heart Fail, March 1, 2003; 5(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|